ArticleInternational journal of molecular sciences2023

Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer.

Etienne J Slapak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.